Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management
Ayalew Tefferi
, Tiziano Barbui
Hematology
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Abnormal Karyotype
26%
Acute Myeloid Leukemia
18%
Alleles
14%
Aspirin
8%
Bone Marrow Examination
13%
Busulfan
25%
Contraindications
9%
Cytogenetics
19%
Hematocrit
19%
Hemoglobins
7%
Hydroxyurea
11%
INCB018424
30%
Incidence
4%
Interferons
8%
Leukocytosis
21%
Mutation
27%
Neoplasms
3%
Neutrophils
7%
Perioperative Care
12%
Pharmaceutical Preparations
7%
Phlebotomy
11%
Polycythemia
12%
Polycythemia Vera
100%
Pregnancy
5%
Primary Myelofibrosis
12%
Pruritus
19%
Risk Management
84%
Splenomegaly
10%
Survival
16%
Therapeutics
12%
Thrombocytosis
12%
Thrombosis
52%
Veins
8%
Venous Thrombosis
18%
Viscera
10%
Y Chromosome
11%